Professional Documents
Culture Documents
INTRODUCTION
INTRODUCTION
YEAR
NEW
CASES/YEAR
2003
948
2004
1013
2005
1005
2006
1017
2007
1039
NEW
CASES
BRONCHOPUL
MONARY
128
BREAST
103
UTERINE
CERVIX
80
COLORECTAL
74
GASTRIC
73
ENT
43
PROSTATE
40
OTHER
407
TOTAL
948
INCIDENCE OF
MALIGNANCY
LUN
G
GASTRIC
CR
BREAST
CERVIX
ENT
PROSTATE
OTHER
TOTAL
2004
166
111
100
74
74
55
43
390
1013
2005
139
94
120
92
68
57
36
399
1005
INCIDENCE OF
MALIGNANCY
LUNG
CR
BREAST
GASTRIC
ENT
UTERINE
CERVIX
PROSTATE
OTHER
TOTAL
2006
143
127
88
80
70
53
42
414
1017
2007
154
123
99
77
74
61
59
392
1039
30-39
40-49
50-59
60-69
>70
2003
1 ( 0,78%)
7 (5,46%)
35
(27,34%)
41
(32,03%)
44
(34,37%)
2004
2 (1,20%)
16 (9,63%)
33
(19,87%)
66
(39,75%)
49
(29,51%)
2005
1 (0,71%)
16 (11,51%)
35
(25,17%)
48
(34,53%)
39
(28,05%)
1 (0,69%)
13 (9,09%)
46
(32,16%)
43
(30,06%)
39
(27,27%)
2006
1019
20-29
1(0,69%)
YEAR 54
Rural 41
2
6 (3,89%)
8 (5,19%)
43
background
(1,29%)
(35,06%)
(26,62%)
SOCIAL BACKGROUND:
PREDOMINANTLY RURAL AREAS(27,92%)
2007
2003
57%
2004
58,4%
2005
56,48%
2006
63,79%
2007
61,11%
SINCE 2004
Colorectal cancer:
slightly equal incidence
in males and females
GASTRIC CANCER :
IN PATIENTS FROM
RURAL AREAS
COLORECTAL NEOPLASM:
SMALL DIFFERENCE
BETWEEN URBAN AND RURAL
AREAS
10-19
20-29
YEARS
2003
30-39
YEARS
40-49
YEARS
50-59
YEARS
60-69
YEARS
>70
YEARS
1 (1,36%)
4 (5,47 %)
9 (12,32%)
27 (36,98%)
32
(43,83%)
2004
1 (0,90%)
1 (0,90%)
4
( 3,60% )
17
(15,31%)
38 (34,23%)
50 (45,04%)
2005
1(1,06%)
2 (2,12%)
2 (2,12%)
13
(13,82%)
25 (26,60%)
51 (54,25%)
2006
1 (1,25%)
1 (1,25%)
14 (17,5% )
32 (40% )
32 ( 40% )
4 (5,19%)
40-49
YEARS
19
(11,68%)
50-59
YEARS
20 (25,97%)
60-69
YEARS
41 (53,24%)
>70
YEARS
2007
COLO
RECT
AL
10-19
20-29
YEARS
3 (3,90%)
30-39
YEARS
2003
5 (6,75
%)
15
(20,27%)
17 (23%)
37 (50%)
3 (3%)
9 ( 9% )
14 (14%)
35 (35%)
39 (39%)
5 (4,16%)
6 (5%)
16
(13,33%)
42 (35%)
50 (41,66%)
2006
5(3,93%)
6 (4,72%)
17(13,38%
)
43 (33,85%)
56 ( 44,09%
)
2007
5 (4,06%)
7 (5,69%)
30
37
44 (35,77%)
2004
2005
1(0,83%)
YEAR
2003
2004
2005
2006
2007
55,33%
55,4%
59,78%
59,09%
65,65%
2003
2004
2005
2006
2007
50%
51,35%
50%
62,26%
60,65%
YEAR
10-19
2003
1
(0,97%)
20-29
years
2004
2005
1
(1,08%)
2006
2007
Cervix
10-19
20-29
ani
4 (5%)
2004
2006
40-49
years
50-59
years
60-69
years
>70
years
5
(4,85%)
25 (24,27
%)
25
( 24,27%)
17
(16,50%)
30
(29,12%)
6 (8,1%)
8 (10,8% )
19 (25,67%)
17
(22,97%)
24
(32,43%)
2
(2,17%)
18
(19,56%)
25 (27,17%)
24(26,08%
)
22
(23,91%)
8(9,09%)
13 (14,77%)
25
(28,40% )
19(21,59%
)
23 (26,13%
)
9
14 (14,14%)
21ages
(21,21%)
28 40-59 years
27
Most uterine cervix cancers
are
reported at
ranging from
2003
2005
30-39
years
1(1,47%
)
2(2,94%)
(9,09%)
30-39
ani
40-49
ani
50-59
ani
(28,28%)
60-69
ani
(27,27%)
>70
ani
11
(13,75%)
20 (25 %)
16 (20%)
13 (16,25%)
16 (20%)
7 (9,45%)
22 (29,72% )
18 (24,32%)
13 (17,56%)
14(18,91%
)
5 (7,35%)
18 (26,47%)
20 (29,41%)
11 (16,17%)
11(16,17%
)
5(9,43%)
15 (28,30)
21
(39,62% )
7 (13,20% )
5( 9,43% )
Incidence is rising
Predominantly in males
PREDOMINANTLY IN
PATIENTS
FROM RURAL AREAS
1019
20-29
years
2003
2004
30-39
years
40-49
years
50-59
years
60-69
years
>70
years
2 (4,65%)
3 (6,97 %)
14
( 32,55%)
13
(30,23%)
11 (25,58%)
13(23,63%
)
9 (16,36%)
22 (40%)
10 (18,18%)
8 (14%)
14 (47,60%)
23
(40,40%)
12 (21%)
12
19
23(32,85%
13
1(1,81%)
2005
2006
2(2,86%)
Rural
2003
55%
2004
58,13%
2005
55,55%
2006
52,38%
2007
59,32%
Prostate
cancer
50-59
years
60-69
years
>70
years
2003
2(5%)
1(2,5%)
28 (70%)
2004
2(4,65%)
7 (16,27)
33 (76,74%)
2005
2 (5,55%)
19 (52,77%)
14 (38,88%)
16(38,09% )
23 (54,76% )
18 (30,50%)
38 (64,40%)
2006
2007
3 (5,08%)
YEAR
Lung
Gastric
CR
Breast
ENT
Cervix
Prostate
Other
Total
2003
121
17,38%
89
12,78%
58
8,33%
47
6,75%
36
5,17%
29
4,16%
23
3,30%
293
42,09%
696
2004
130
21,66%
102
17%
57
9,5%
39
6,5%
42
7%
29
4,83%
23
3,83%
178
29,66%
600
2005
143
18,33%
92
11,79%
77
9,87%
39
5%
35
4,48%
27
3,46%
25
3,20%
342
43,84%
780
2006
123
15,12%
71
8,73%
71
8,73%
44
5,41%
41
5,04%
30
3,69%
24
2,95%
409
50,30%
813
2007
124
12,02%
71
6,88%
59
5,72%
39
3,78%
39
3,78%
30
2,90%
28
2,71%
635
61,59%
1031
CONCLUSIONS
Incidence increasing during 2003-2007 for most of the studied
localisations of the malignancy, except gastric cancer,
which is decreasing since 2004